[
  {
    "ts": "2025-11-30T09:05:00+00:00",
    "headline": "2 Top Dividend Stocks to Buy and Hold",
    "summary": "Patience will be rewarded for those who stick with these two healthcare stocks.",
    "url": "https://www.fool.com/investing/2025/11/30/2-top-dividend-stocks-to-buy-and-hold/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "64103682-c3b7-35dd-9c1c-0cd8e8abbc91",
      "content": {
        "id": "64103682-c3b7-35dd-9c1c-0cd8e8abbc91",
        "contentType": "STORY",
        "title": "2 Top Dividend Stocks to Buy and Hold",
        "description": "",
        "summary": "Patience will be rewarded for those who stick with these two healthcare stocks.",
        "pubDate": "2025-11-30T09:05:00Z",
        "displayTime": "2025-11-30T09:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/188cf2162b8ce6a377318031f75d4ed8",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Doctor and patient in hospital room.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RjAk3UgLO3rA6V_Jv19I2A--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/188cf2162b8ce6a377318031f75d4ed8.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/seL0rqahGcf.UlH.GnjkKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/188cf2162b8ce6a377318031f75d4ed8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/30/2-top-dividend-stocks-to-buy-and-hold/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-top-dividend-stocks-buy-090500588.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-30T11:30:00+00:00",
    "headline": "3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio",
    "summary": "If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.",
    "url": "https://www.fool.com/investing/2025/11/30/stocks-buy-and-hold-long-term-pfe-mdt-jnj/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c272cb2c-b6f1-357f-b928-231383952028",
      "content": {
        "id": "c272cb2c-b6f1-357f-b928-231383952028",
        "contentType": "STORY",
        "title": "3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio",
        "description": "",
        "summary": "If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.",
        "pubDate": "2025-11-30T11:30:00Z",
        "displayTime": "2025-11-30T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e9e28ebb54e76c7551645917254f10d1",
          "originalWidth": 1199,
          "originalHeight": 797,
          "caption": "Three people in business clothing standing on boxes in a desert looking through telescopes at the horizon.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Pf8iznXd36qL8vMIh6JU4A--~B/aD03OTc7dz0xMTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/e9e28ebb54e76c7551645917254f10d1.cf.webp",
              "width": 1199,
              "height": 797,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gIv50x31YDzXwcbzOdLJqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e9e28ebb54e76c7551645917254f10d1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/30/stocks-buy-and-hold-long-term-pfe-mdt-jnj/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-buy-hold-long-113000925.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-30T19:01:44+00:00",
    "headline": "JNJ to Acquire Halda Therapeutics for $3.05 Billion to Boost Oncology Pipeline",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Boring Dividend Stocks to Buy. On Nov‌ember 18, Johnson & Johnson (NYSE:JNJ) revealed that it plans to acquire pr‌ivately held Halda​ Ther⁠apeutics f‍o‌r $3.05 billion i‍n c​ash,‍ a move intended to strengthen its pos‍ition in therapies focused on solid tumors and prostate cancer. The p‍urcha‌se […]",
    "url": "https://finance.yahoo.com/news/jnj-acquire-halda-therapeutics-3-190144444.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "3a3ad9e3-baf5-3dc8-b5cb-1dc414ae0be4",
      "content": {
        "id": "3a3ad9e3-baf5-3dc8-b5cb-1dc414ae0be4",
        "contentType": "STORY",
        "title": "JNJ to Acquire Halda Therapeutics for $3.05 Billion to Boost Oncology Pipeline",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Boring Dividend Stocks to Buy. On Nov‌ember 18, Johnson & Johnson (NYSE:JNJ) revealed that it plans to acquire pr‌ivately held Halda​ Ther⁠apeutics f‍o‌r $3.05 billion i‍n c​ash,‍ a move intended to strengthen its pos‍ition in therapies focused on solid tumors and prostate cancer. The p‍urcha‌se […]",
        "pubDate": "2025-11-30T19:01:44Z",
        "displayTime": "2025-11-30T19:01:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "JNJ to Acquire Halda Therapeutics for $3.05 Billion to Boost Oncology Pipeline",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qG_90ptmVmYmlFzMjoC0Yw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q3JcjOP_BI3o_9_ANEkK.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jnj-acquire-halda-therapeutics-3-190144444.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jnj-acquire-halda-therapeutics-3-190144444.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ITCI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-30T19:27:35+00:00",
    "headline": "BMY Gains Attention as Bayer Reports FXIa Trial Success",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best Boring Dividend Stocks to Buy. Bayer repor⁠t​ed positive Phase‌ 3 result⁠s for its FXIa inhi‍bitor as​undexian, h‌itting key efficacy an‍d safety targets and dr‌awing renewed attention to the broader FXIa drug class. Morg​a⁠n Stanley noted this could increase interest i‌n s⁠imilar treatments from Bristol-Myers Squibb […]",
    "url": "https://finance.yahoo.com/news/bmy-gains-attention-bayer-reports-192735842.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "deb3a482-2562-3533-b160-987de41b5cbe",
      "content": {
        "id": "deb3a482-2562-3533-b160-987de41b5cbe",
        "contentType": "STORY",
        "title": "BMY Gains Attention as Bayer Reports FXIa Trial Success",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best Boring Dividend Stocks to Buy. Bayer repor⁠t​ed positive Phase‌ 3 result⁠s for its FXIa inhi‍bitor as​undexian, h‌itting key efficacy an‍d safety targets and dr‌awing renewed attention to the broader FXIa drug class. Morg​a⁠n Stanley noted this could increase interest i‌n s⁠imilar treatments from Bristol-Myers Squibb […]",
        "pubDate": "2025-11-30T19:27:35Z",
        "displayTime": "2025-11-30T19:27:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "BMY Gains Attention as Bayer Reports FXIa Trial Success",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmy-gains-attention-bayer-reports-192735842.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmy-gains-attention-bayer-reports-192735842.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-30T19:25:00+00:00",
    "headline": "Analysts Note Stronger Outlook as Kimberly-Clark (KMB) Deepens Its Consumer Health Footprint",
    "summary": "Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 15 Best Boring Dividend Stocks to Buy. On⁠ November 13, Argus analy⁠st John St‌aszak upgraded Kimberly-Clark Corporation (NASDAQ:KMB) to a Buy ratin‍g​ from Hold and set a $120 price targ‌et, according to a report by The Fly. He pointed out that the stock has b‌een l‍agging lately, but […]",
    "url": "https://finance.yahoo.com/news/analysts-note-stronger-outlook-kimberly-192500853.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "02c5bcc4-0a97-3416-81ac-be2be56881bd",
      "content": {
        "id": "02c5bcc4-0a97-3416-81ac-be2be56881bd",
        "contentType": "STORY",
        "title": "Analysts Note Stronger Outlook as Kimberly-Clark (KMB) Deepens Its Consumer Health Footprint",
        "description": "",
        "summary": "Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 15 Best Boring Dividend Stocks to Buy. On⁠ November 13, Argus analy⁠st John St‌aszak upgraded Kimberly-Clark Corporation (NASDAQ:KMB) to a Buy ratin‍g​ from Hold and set a $120 price targ‌et, according to a report by The Fly. He pointed out that the stock has b‌een l‍agging lately, but […]",
        "pubDate": "2025-11-30T19:25:00Z",
        "displayTime": "2025-11-30T19:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f15347b2814b43cbbdf31f1e61fca9d8",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Analysts Note Stronger Outlook as Kimberly-Clark (KMB) Deepens Its Consumer Health Footprint",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PujmtQzaJz6dWea3foRa4A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f15347b2814b43cbbdf31f1e61fca9d8.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_v9NwwLC1j3Mz2Qu6nVVfw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f15347b2814b43cbbdf31f1e61fca9d8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysts-note-stronger-outlook-kimberly-192500853.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-note-stronger-outlook-kimberly-192500853.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KMB"
            },
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]